Atlas Trials

Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

Clinical trial NCT01015339 · UNKNOWN

Trial details

NCT number
NCT01015339
Sponsor
Peking University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced Gastric Cancer
Start date
2009-11-01
Primary completion
2015-08-01
Enrollment
320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.